NBP CIK: 1778016

NovaBridge Biosciences

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
FY21:
0.04
FY22:
−0.01
FY23:
–
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
FY21:
−1.17
FY22:
−0.06
FY23:
−0.07
FY24:
−0.05
FY25:
−0.09
(positive)
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−0.09
(positive)
Change from FY21 to FY25
FY21:
−2.33
FY22:
−0.14
FY23:
−0.08
FY24:
−0.05
FY25:
−0.09
(positive)
Change from FY21 to FY25
FY21:
−2.33
FY22:
−0.37
FY23:
−0.21
FY24:
−0.02
FY25:
−0.05

Data sources:SEC EDGARTwelve Data